Ligand validation:4BRA

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BRA_MES_B_1395	94%	15%	0.073	0.973	1.98	1.84	1	5	0	0	100%	0.75
4BRA_MES_A_1396	91%	9%	0.086	0.973	2.84	1.63	1	2	1	0	100%	0.75
4BRG_MES_B_1399	99%	11%	0.056	0.986	1.72	2.42	3	3	0	0	100%	1
4BRC_MES_A_1398	98%	23%	0.058	0.984	1.32	1.83	2	4	0	0	100%	1
4BRI_MES_B_1397	96%	17%	0.066	0.976	1.75	1.87	1	4	0	0	100%	1
4BRK_MES_A_1397	96%	5%	0.064	0.972	1.89	3.37	1	8	0	0	100%	0.75
4BRF_MES_B_1398	93%	7%	0.077	0.972	2.28	2.48	2	5	2	0	100%	0.75
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.